ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor-Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy
Tomas Reinert, Susana Ramalho, Vivian CA Vasconcelos, Leonardo R Silva, Ana Elisa R Silva, Camila A Andrade, Maria Beatriz PL Kraft, Guilherme P Coelho, Jovana Mandelli, Monique Binotto, Cesar Cabello, Geisilene RP Silva, Jose Bines, Carlos H Barrios, Matthew J Ellis and Marcia S Graudenz.
Prevalence of patients with indication of genetic evaluation for hereditary breast and ovarian syndrome in the Brazilian cohort study – AMAZONA III
Alessandra Borba Anton de Souza, Daniela Rosa, Antonio LuiZ Frasson, Felipe Pereira Zerwes, Nathalia Cunha Rossato, Patricia Asthon-Prolla, Sergio Simon, Jose Bines, Carlos Barrios, Alessandra Morelle, Carlos Alberto Sampaio Filho, Max Mano, Rafaela Gomes and Gustavo Werutsky.
Comprehensive genomic profiling of non-small cell lung cancer in Brazil (GBOT 0118/LACOG 0418).
S. Mascarenhas, A. Gelatti, V. De Lima, L.H. Araújo, C. Baldotto, C. Mathias, M. Zukin, G. Werutsky, P.R. Nunes Filho, R. Gomes, G. Castro.
Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) versus AAP+APA in patients with advanced prostate cancer with noncastrate testosterone levels: (LACOG 0415)
Fernando C. Maluf, Andre P. Fay, Vinícius Carrera Souza, Fabio A. B. Schutz, Oren Smaletz, Daniel Herchenhorn, Vanessa Fabricio, Rosemarie Gidekel, Eduardo Cronemberger, Murilo Luz, Suelen P. S. Martins, David Queiroz Borges Muniz, Fabio Andre Franke, Fabio Peixoto, Flavio Mavignier Carcano, Andrea Juliana Gomes, Felipe Cruz, Rafaela Gomes, Paulo Ricardo Santos Nunes Filho, Gustavo Werutsky - Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020)